Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 34Neoplasm Metastasis 3Osteoporosis 2Fractures, Bone 2Arthralgia 2Polycystic Ovary Syndrome 1Neurotoxicity Syndromes 1Neoplasms, Hormone-Dependent 1Fatigue 1Estrogen Receptor and/or Progesterone Receptor Positive 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1

Interventions

ribociclib 1Pharmacogenomic Variants 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Estrogen Receptor and/or Progesterone Receptor Positive × Aromatase Inhibitors × Clear all
NCT03477396 2024-02-20

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Completed
2 enrolled 13 charts
Breast

Estrogen Receptor and/or Progesterone Receptor Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡